Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT05761132
Status:
UNKNOWN
Last Update Posted:
2023-03-09
First Post:
2022-08-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study
Sponsor:
Leiden University Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-11
First Submit QC Date:
None
Study First Post Date:
2023-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-07
Last Update Post Date:
2023-03-09
Last Update Post Date Type:
ACTUAL